|

JNJ-101556143 Clinical Trials

3 actively recruiting trials across 3 locations

▲ +1 trial since September 2026

Also known as: HLD-0915

Pipeline

Phase 1: 2Phase 2: 1

Top Sponsors

  • Janssen Research & Development, LLC3

Indications

  • Cancer3
  • Prostatic Neoplasms2
  • Metastatic Hormone-sensitive Prostate Cancer1
  • Metastatic Castration-resistant Prostate Neoplasms1
  • Advanced Prostate Cancer1

Aurora, Colorado1 trial

Phase 1

Sarasota, Florida1 trial

Lafayette, Louisiana1 trial

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.